Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL526603

O=C(O)C(F)(F)F.O=C1CCc2ccccc2N1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.71
MAPK13 O15264 1/20 0.71
MAPK12 P53778 1/20 0.71
MAPK11 Q15759 1/20 0.71
MAPK14 Q16539 1/20 0.71
MAPT P10636 1/20 0.57
AHR P35869 1/20 0.49
PDK2 Q15119 1/20 0.49
KIF11 P52732 4/20 0.47
CRBN Q96SW2 2/20 0.44
MAOA P21397 4/20 0.43
MAOB P27338 4/20 0.43
CA9 Q16790 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
BRD4 O60885 1/20 0.41
CREBBP Q92793 1/20 0.41
PTK2B Q14289 1/20 0.41
MAP4K1 Q92918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL527380 0.91 MAPT (0.73) NPC1MAPK13MAPK12MAPK11MAPK14
Bicarbonate SCHEMBL9232742 0.88 NPC1 (0.85) NPC1MAPK13MAPK12MAPK11MAPK14
Oxalic Acid SCHEMBL8183265 0.86 NPC1 (0.81) NPC1MAPK13MAPK12MAPK11MAPK14
Oxindole SCHEMBL4488236 0.85 AHR (0.70) NPC1MAPK13MAPK12MAPK11MAPK14
Oxindole SCHEMBL29921679 0.85 AHR (0.70) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL29365738 0.84 NPC1 (1.00) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL10032 0.84 NPC1 (1.00) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL4227502 0.84 NPC1 (1.00) NPC1MAPK13MAPK12MAPK11MAPK14
Hydrochloric Acid SCHEMBL30293252 0.82 NPC1 (0.96) NPC1MAPK13MAPK12MAPK11MAPK14
Trifluoroacetic Acid SCHEMBL3430565 0.81 AHR (0.46) NPC1MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598500-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Rigel Pharmaceuticals, Inc. (US) 2013-06-05 EP claimed
WO-2012015972-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 WO claimed